Medtronic PLC (MDT)
$82.92 -$0.42 (-0.50%) 3:20 AM 12/12/24
NYSE | $USD | Medical DevicesStock Data
-
Market Cap
$107.73B -
Day's Range
$82.97 - $83.97 -
Volume
5,865,934 -
52 Week Low / High
$75.37 - $92.68 -
PE Ratio
25.69x -
PEG Ratio
1.53 -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 11
- Strong Buy
- 6
- Buy
- 14
- Hold
- 1
- Sell
- 1
- Strong Sell
- $90.44
- Target Price
Company News
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024
Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...
-
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe — Oct 11th, 2024
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European Union. European surgeons have already performed the first series of cases using the device. ...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe — Oct 11th, 2024
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European Union. European surgeons have already performed the first series of cases using the device. ...
-
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe — Oct 11th, 2024
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European Union. European surgeons have already performed the first series of cases using the device. ...
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business — Oct 11th, 2024
GE HealthCare GEHC completed the acquisition of Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business, a move aimed at reshaping its ultrasound portfolio. The deal, signed in July 2024, is valued at $51 million and aligns with GE HealthCare’s broad...
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024
Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe — Oct 11th, 2024
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European Union. European surgeons have already performed the first series of cases using the device. ...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe — Oct 11th, 2024
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European Union. European surgeons have already performed the first series of cases using the device. ...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business — Oct 11th, 2024
GE HealthCare GEHC completed the acquisition of Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business, a move aimed at reshaping its ultrasound portfolio. The deal, signed in July 2024, is valued at $51 million and aligns with GE HealthCare’s broad...
-
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business — Oct 11th, 2024
GE HealthCare GEHC completed the acquisition of Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business, a move aimed at reshaping its ultrasound portfolio. The deal, signed in July 2024, is valued at $51 million and aligns with GE HealthCare’s broad...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024
Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...
-
SNN Boosts Knee Revision Surgery With Its LEGION Hinged Knee System — Oct 11th, 2024
Smith & Nephew SNATS SNN recently launched its LEGION Hinged Knee System, which incorporates its proprietary OXINIUM Technology. The launch marks a significant advancement in the field of knee revisions, with the new system designed to improve the outcomes for patients requiring complex kn...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe — Oct 11th, 2024
AtriCure, Inc. ATRC, a leading innovator in surgical treatments for atrial fibrillation (Afib), has announced regulatory approval for its EnCompass Clamp in CE-marked countries within the European Union. European surgeons have already performed the first series of cases using the device. ...
-
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business — Oct 11th, 2024
GE HealthCare GEHC completed the acquisition of Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business, a move aimed at reshaping its ultrasound portfolio. The deal, signed in July 2024, is valued at $51 million and aligns with GE HealthCare’s broad...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing — Oct 11th, 2024
Medtronic (MDT) closed the latest trading day at $89.36, indicating a +0.57% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.61%. Meanwhile, the Dow experienced a rise of 0.97%, and the technology-dominated Nasdaq saw an increase of 0....
-
Boston Scientific stock down as Needham cuts to Hold on growth concerns — Oct 18th, 2024
Investing.com -- Shares in Boston Scientific (NYSE:BSX) fell more than 1% in premarket trading Friday after analysts at Needham&Co. downgraded the stock to Hold from Buy, citing several concerns about the company's future growth and market competition. The investment firm pointed to an an...
-
Is There Now An Opportunity In Medtronic plc (NYSE:MDT)? — Oct 12th, 2024
Today we're going to take a look at the well-established Medtronic plc (NYSE:MDT). The company's stock saw a decent share price growth of 16% on the NYSE over the last few months. The company is now trading at yearly-high levels following the recent surge in its share price. As a large-cap...
-
Does Medtronic plc's (NYSE:MDT) Weak Fundamentals Mean That The Market Could Correct Its Share Price? — Oct 19th, 2024
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 16% over the last three months. We, however wanted to have a closer look at its key financial indicators as the markets usually pay for long-term fundamentals, and in this case, they don't look ...
Portfolio
Comprised of 1 portfolios